Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 9 results.
User Information
Export Records
  1. 1.   Preclinical Evaluation of the FGFR-Family Inhibitor Futibatinib for Pediatric Rhabdomyosarcoma
  2. Wu, Jerry T; Cheuk, Adam; Isanogle,Kristine; Robinson,Christina; Zhang, Xiaohu; Ceribelli, Michele; Beck, Erin; Shinn, Paul; Klumpp-Thomas, Carleen; Wilson, Kelli M; McKnight, Crystal; Itkin, Zina; Sotome, Hiroshi; Hirai, Hiroshi; Calleja, Elizabeth; Wacheck, Volker; Gouker, Brad; Peer, Cody J; Corvalan, Natalia; Milewski, David; Kim, Yong Y; Figg, William D; Edmondson,Elijah; Thomas, Craig J; Difilippantonio,Simone; Wei, Jun S; Khan, Javed
  3. Cancers. 2023, Aug 09; 15(16):
  1. 2.   ERK phosphorylation is dependent on cell adhesion in a subset of pediatric sarcoma cell lines
  2. Yoon, Hye-Young; Maron, Ben Y; Girald-Berlingeri, Sofia; Gasilina, Anjelika; Gollin, Josephine C; Jian, Xiaoying; Akpan, Itoro; Yohe,Marielle; Randazzo, Paul A; Chen, Pei-Wen
  3. Biochimica et Biophysica Acta. Molecular Cell Research. 2022, Apr 03; 1869(8):
  1. 3.   Primary Meningeal Rhabdomyosarcoma of the Spinal Cord of a Young Dog with Neuromelanocytosis and Multiple Cutaneous Neurofibromas
  2. Hoon-Hanks, L L; Frank, C B; Edmondson, Elijah
  3. Journal of comparative pathology. 2018, Nov; 165: 57-61.
  1. 4.   Genome-Wide Identification of PAX3-FKHR Binding Sites in Rhabdomyosarcoma Reveals Candidate Target Genes Important for Development and Cancer
  2. Cao, L. A.; Yu, Y. K.; Bilke, S.; Walker, R. L.; Mayeenuddin, L. H.; Azorsa, D. O.; Yang, F.; Pineda, M.; Helman, L. J.; Meltzer, P. S.
  3. Cancer Research. 2010, Aug; 70(16): 6497-6508.
  1. 5.   Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models
  2. Taylor, J. G.; Cheuk, A. T.; Tsang, P. S.; Chung, J. Y.; Song, Y. K.; Desai, K.; Yu, Y. L.; Chen, Q. R.; Shah, K.; Youngblood, V.; Fang, J.; Kim, S. Y.; Yeung, C.; Helman, L. J.; Mendoza, A.; Ngo, V.; Staudt, L. M.; Wei, J. S.; Khanna, C.
  3. Journal of Clinical Investigation. 2009 119(11): 3395-3407.
  1. 6.   A pilot study of consolidative immunotherapy in patients with high-risk pediatric sarcomas
  2. Mackall, C. L.; Rhee, E. H.; Read, E. J.; Khuu, H. M.; Leitman, S. F.; Bernstein, D.; Tesso, M.; Long, L. M.; Grindler, D.; Merino, M.; Kopp, W.; Tsokos, M.; Berzofsky, J. A.; Helman, L. J.
  3. Clinical Cancer Research. 2008 14(15): 4850-4858.
  1. 7.   ARF functions as a melanoma tumor suppressor by inducing p53-independent senescence
  2. Ha, L.; Ichikawa, T.; Anver, M.; Dickins, R.; Lowe, S.; Sharpless, N. E.; Krimpenfort, P.; DePinho, R. A.; Bennett, D. C.; Sviderskaya, E. V.; Merlino, G.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2007, Jun; 104(26): 10968-10973.
  1. 8.   An imprinted locus epistatically influences Nstr1 and Nstr2 to control resistance to nerve sheath tumors in a neurofibromatosis type 1 mouse model
  2. Reilly, K. M.; Broman, K. W.; Bronson, R. T.; Tsang, S.; Loisel, D. A.; Christy, E. S.; Sun, Z. H.; Diehl, J.; Munroe, D. J.; Tuskan, R. G.
  3. Cancer Research. 2006, JAN 1; 66(1): 62-68.
  1. 9.   Biochemical correlates of mTOR inhibition by the rapamycin ester CCI-779 and tumor growth inhibition
  2. Dudkin, L.; Dilling, M. B.; Cheshire, P. J.; Harwood, F. C.; Hollingshead, M.; Arbuck, S. G.; Travis, R.; Sausville, E. A.; Houghton, P. J.
  3. Clinical Cancer Research. 2001 7(6): 1758-1764.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel